{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:52:39Z","timestamp":1792036359944,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.ejca.2005.04.033","type":"journal-article","created":{"date-parts":[[2005,7,21]],"date-time":"2005-07-21T20:40:07Z","timestamp":1121978407000},"page":"1724-1730","source":"Crossref","is-referenced-by-count":58,"title":["Effective palliation by low dose local radiotherapy for recurrent and\/or chemotherapy refractory non-follicular lymphoma patients"],"prefix":"10.1016","volume":"41","author":[{"given":"R.L.M.","family":"Haas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph.","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van der Hulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bartelink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2005.04.033_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900120102","article-title":"Potential role for low dose limited-field radiation therapy (2\u00d72 Grays) in advanced low-grade non-Hodgkin\u2019s lymphomas","volume":"12","author":"Ganem","year":"1994","journal-title":"Hemat Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-8140(96)01854-3","article-title":"Low dose palliative radiotherapy in low grade non-Hodgkin\u2019s lymphoma","volume":"42","author":"Sawyer","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0360-3016(01)01626-1","article-title":"A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment","volume":"51","author":"Girinsky","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0360-3016(02)03050-X","article-title":"Phase II study of palliative low-dose local radiotherapy in disseminated indolent non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukaemia","volume":"54","author":"Johannsson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib5","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib6","series-title":"WHO classification of tumours, pathology and genetics, tumours of the haematopoietic and lymphoid tissues","year":"2001"},{"key":"10.1016\/j.ejca.2005.04.033_bib7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib8","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/annonc\/mdg414","article-title":"Limited-stage mantle-cell lymphoma","volume":"14","author":"Leitch","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0360-3016(81)90183-8","article-title":"The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukaemia: an ECOG study. Part I: total body irradiation-response and toxicity","volume":"7","author":"Rubin","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1182\/blood.V69.6.1642.1642","article-title":"A randomized prospective comparison of chemotherapy to total body irradiation as initial treatment for the indolent lymphoproliferative diseases","volume":"69","author":"Jacobs","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2005.04.033_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3109\/07357909109084637","article-title":"Feasibility of total body irradiation in chronic lymphocytic leukaemia and low-grade non-Hodgkin\u2019s lymphomas","volume":"9","author":"Roncadin","year":"1991","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ejca.2005.04.033_bib12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1097-0142(19940801)74:3<978::AID-CNCR2820740330>3.0.CO;2-B","article-title":"Total body irradiation and prednimustine in chronic lymphocytic leukaemia and low grade non-Hodgkin\u2019s lymphomas. A 9-year experience at a single institution","volume":"74","author":"Roncadin","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2005.04.033_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(00)00167-5","article-title":"The role of low-dose total body irradiation in treatment of non-Hodgkin\u2019s lymphoma: a new look at an old method","volume":"56","author":"Safwat","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","article-title":"Treatment-related myelodysplasia and acute leukaemia in non-Hodgkin\u2019s lymphoma patients","volume":"21","author":"Armitage","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib15","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0360-3016(03)00767-3","article-title":"Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes","volume":"57","author":"Fung","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0161-6420(01)00837-5","article-title":"Extranodal marginal zone B-cell lymphoma of the lacrimal gland associated with crystal-storing histiocytosis","volume":"109","author":"Coupland","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejca.2005.04.033_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0360-3016(03)00506-6","article-title":"Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification","volume":"57","author":"Hasegawa","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ophtha.2003.09.049","article-title":"Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma","volume":"111","author":"Matsuo","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejca.2005.04.033_bib19","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1200\/JCO.2003.06.085","article-title":"Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome","volume":"21","author":"Tsang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib20","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","article-title":"Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy","volume":"55","author":"Martinet","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib21","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone","volume":"16","author":"Schechter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ijrobp.2003.09.002","article-title":"Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma","volume":"58","author":"Park","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00000421-200102000-00012","article-title":"Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case report and review of literature","volume":"24","author":"Agulnik","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2005.04.033_bib24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0360-3016(01)02714-6","article-title":"Treatment outcome of mucosa-associated lymphoid tissue\/marginal zone non-Hodgkin\u2019s lymphoma","volume":"52","author":"Hitchcock","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2005.04.033_bib25","first-page":"346","article-title":"Whole-bladder irradiation and doxorubicin-containing chemotherapy as successful treatment for a primary mucosa-associated lymphoid tissue lymphoma of the bladder","volume":"72","author":"Kawakami","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ejca.2005.04.033_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2005.04.033_bib27","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1038\/sj.onc.1206826","article-title":"Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma","volume":"22","author":"M\u2019kacher","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2005.04.033_bib28","first-page":"285","article-title":"The first James Kirk memorial lecture. What next in fractionated radiotherapy?","volume":"6","author":"Fowler","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2005.04.033_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1667\/0033-7587(2000)153[0599:TIOLDT]2.0.CO;2","article-title":"The immunobiology of low-dose total-body irradiation: more questions than answers","volume":"153","author":"Safwat","year":"2000","journal-title":"Radiat Res"},{"key":"10.1016\/j.ejca.2005.04.033_bib30","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2003.11.017","article-title":"In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients","volume":"59","author":"Haas","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905004399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804905004399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T09:01:36Z","timestamp":1586336496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804905004399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0959804905004399"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2005.04.033","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}